Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNEC-I Therapy for Corneal Endothelial Dysfunction
NCT07711561Phase 1Recruiting
- Sponsor
- Singapore Eye Research Institute
- Start
- Jun 2026
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in corneal endothelial dysfunction and bullous keratopathy (PBK), sponsored by Singapore Eye Research Institute. Primary endpoint: Best Spectacle-Corrected Visual Acuity at 12 months. Started Jun 2026; status: recruiting.
02
Conditions
corneal endothelial dysfunctionbullous keratopathy (PBK)
Beyond the preview
Go deeper on NCT07711561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07711561.